Literature DB >> 12363386

Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression.

Guoqiang Xing1, Mikulas Chavko, Li-Xin Zhang, Shutong Yang, Robert M Post.   

Abstract

To further understand the potential role of nitric oxide synthase (NOS) in schizophrenia and affective disorders, we determined the calcium-dependent constitutive NOS (cNOS) enzymatic activity and protein levels in the prefrontal cortex of postmortem brains of patients with unipolar, bipolar, and schizophrenic disorders and non-psychiatric controls (n = 15 for each group). Protein levels of two NOS isoforms, nNOS and eNOS, were not significantly different from the non-psychiatric controls in any of the patient groups. However, cNOS activity was significantly lower in schizophrenic patients (mean +/- S.E. = 19.1 +/- 3.2 cpm/microg/45 min) than in the control group (28.5 +/- 3.4, P < 0.05). Trends of lower cNOS activity were found in unipolar (20.3 +/- 2.6, P = 0.062) and bipolar patients (20.8 +/- 3.0, P = 0.079). Males had significantly higher NOS activity (25.4 +/- 2, n = 36, P = 0.01) than females (17.3 +/- 1.9, n = 24), but no significant diagnosis and gender interactions were found. To minimize potential effects of extended postmortem interval (PMI) on NOS activity and proteins, the PMI was limited to 30 h and the data (n = 38) were re-analyzed. cNOS activity was significantly (P < 0.05) lower in patients with schizophrenia (15.8 +/- 5.6, P = 0.026) and unipolar depression (18.8 +/- 3.2, P = 0.042) but not in patients with bipolar illness (22.9 +/- 3.4, P = 0.21) than in the control group (29.5 +/- 3.7). cNOS activity was significantly correlated with brain pH in the total sample (r = 0.28, P < 0.05, n = 60) and in the PMI controlled subgroup (r = 0.43, P < 0.01, n = 38). Our data provide evidence of reduced cNOS activity in the postmortem brains of patients with schizophrenia and depression. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363386     DOI: 10.1016/s0920-9964(01)00388-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.

Authors:  Stephen Sammut; Kristina E Bray; Anthony R West
Journal:  Psychopharmacology (Berl)       Date:  2007-01-06       Impact factor: 4.530

2.  An association between the reduced levels of SLC1A2 and GAD1 in the dorsolateral prefrontal cortex in major depressive disorder: possible involvement of an attenuated RAF/MEK/ERK signaling pathway.

Authors:  Dong Hoon Oh; Daeyoung Oh; Hyeon Son; Maree J Webster; Cyndi S Weickert; Seok Hyeon Kim
Journal:  J Neural Transm (Vienna)       Date:  2014-03-22       Impact factor: 3.575

3.  Endothelial nitric oxide synthase in rat brain is downregulated by sub-chronic antidepressant treatment.

Authors:  Yuta Yoshino; Shinichiro Ochi; Kiyohiro Yamazaki; Shunsuke Nakata; Jun-Ichi Iga; Shu-Ichi Ueno
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

Review 4.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.

Authors:  Aikaterini Trevlopoulou; Ntilara Touzlatzi; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

6.  Low nNOS protein in the locus coeruleus in major depression.

Authors:  B Karolewicz; K Szebeni; C A Stockmeier; L Konick; J C Overholser; G Jurjus; B L Roth; G A Ordway
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

Review 7.  Possible mechanisms of neurodegeneration in schizophrenia.

Authors:  Iván Pérez-Neri; Jesús Ramírez-Bermúdez; Sergio Montes; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-09-28       Impact factor: 3.996

8.  Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls.

Authors:  Zhifang Zhang; Xiongying Chen; Ping Yu; Qiumei Zhang; Xiaochen Sun; Huang Gu; Hao Zhang; Jinguo Zhai; Min Chen; Boqi Du; Xiaoxiang Deng; Feng Ji; Chuanyue Wang; Yutao Xiang; Dawei Li; Hongjie Wu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2014-12-10       Impact factor: 7.853

9.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

10.  Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.

Authors:  James D Clelland; Laura L Read; Jennifer Smeed; Catherine L Clelland
Journal:  Psychiatry Res       Date:  2018-02-08       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.